about
Anti-CD38 autoantibodies in type? diabetesHuman CD38 (ADP-ribosyl cyclase) is a counter-receptor of CD31, an Ig superfamily memberA rapid lateral flow immunoassay for the detection of tyrosine phosphatase-like protein IA-2 autoantibodies in human serumNavigating diabetes-related immune epitope data: resources and tools provided by the Immune Epitope Database (IEDB)Immunization of HLA class I transgenic mice identifies autoantigenic epitopes eliciting dominant responses in type 1 diabetes patients.Antibodies recognizing Mycobacterium avium paratuberculosis epitopes cross-react with the beta-cell antigen ZnT8 in Sardinian type 1 diabetic patientsRetinoids in breast cancer prevention and treatment. A review of the literature.Long-lasting immune responses 4 years after GAD-alum treatment in children with type 1 diabetes.T cells recognizing a peptide contaminant undetectable by mass spectrometry.Evidence that nasal insulin induces immune tolerance to insulin in adults with autoimmune diabetesA simple and fast non-radioactive bridging immunoassay for insulin autoantibodiesMHC class II tetramers made from isolated recombinant α and β chains refolded with affinity-tagged peptides.CD38 expressed on human monocytes: a coaccessory molecule in the superantigen-induced proliferation.Viral infection prevents diabetes by inducing regulatory T cells through NKT cell-plasmacytoid dendritic cell interplay.Single insulin-specific CD8+ T cells show characteristic gene expression profiles in human type 1 diabetes.MHC Class II tetramers and the pursuit of antigen-specific T cells: define, deviate, delete.Characterization of immune response to novel HLA-A2-restricted epitopes from zinc transporter 8 in type 1 diabetes.Functional avidity directs T-cell fate in autoreactive CD4+ T cells.Three sensitive assays do not provide evidence for circulating HuD-specific T cells in the blood of patients with paraneoplastic neurological syndromes with anti-Hu antibodies.HLA-B7-restricted islet epitopes are differentially recognized in type 1 diabetic children and adults and form weak peptide-HLA complexes.Targeting T lymphocytes for immune monitoring and intervention in autoimmune diabetes.Reduced naïve CD8(+) T-cell priming efficacy in elderly adults.Zinc transporter (ZnT)8(186-194) is an immunodominant CD8+ T cell epitope in HLA-A2+ type 1 diabetic patients.T cells in the pathogenesis of type 1 diabetes.Loss of immune tolerance to IL-2 in type 1 diabetes.Measurement of CD8 T cell responses in human type 1 diabetes.Characterization of a CD38-like 78-kilodalton soluble protein released from B cell lines derived from patients with X-linked agammaglobulinemia.Long-term exposure to Myozyme results in a decrease of anti-drug antibodies in late-onset Pompe disease patients.Current approaches to measuring human islet-antigen specific T cell function in type 1 diabetes.Isolation and preservation of peripheral blood mononuclear cells for analysis of islet antigen-reactive T cell responses: position statement of the T-Cell Workshop Committee of the Immunology of Diabetes Society.Beyond the hormone: insulin as an autoimmune target in type 1 diabetes.Pathogenic and regulatory T cells in type 1 diabetes: losing self-control, restoring it, and how to take the temperature.T cell recognition of autoantigens in human type 1 diabetes: clinical perspectivesImmune biomarkers in immunotherapeutic trials for type 1 diabetes: cui prodest?Insulin and type 1 diabetes: immune connections.Biomarkers for immune intervention trials in type 1 diabetes.Infectious triggers in type 1 diabetes: is there a case for epitope mimicry?Priming of Qualitatively Superior Human Effector CD8+ T Cells Using TLR8 Ligand Combined with FLT3 Ligand.Immunology of Diabetes Society T-Cell Workshop: HLA class II tetramer-directed epitope validation initiative.HLA class I epitope discovery in type 1 diabetes.
P50
Q24652207-877BA9B3-0586-4572-B83E-F6F54D5587DEQ28268352-EC43B90E-432F-415A-8ACA-3D3F52112F4AQ28390646-954335A3-0327-47A9-92A7-2BCF34CEF0D9Q30843737-4C0082AD-E126-4C06-8641-CB5DFF7BF0B8Q33285140-75328FE7-42F7-4248-99B8-72E0F01B3344Q34064846-9C3E241C-66F5-443D-89F7-5A8188548DCAQ34072384-6C621914-C560-4559-A55E-2E5BA7223C01Q34103574-041D81DE-B615-4D91-A4CD-6181F3B37956Q34110455-C39D1B94-BD33-48A0-873A-C2CA11A00DEEQ34718808-C2D0F6DE-0949-452A-87AB-A2D15F0E380FQ34902056-07BFF966-2B65-45F8-9927-DD0B5E4B8856Q34984511-9EEDB1A3-43F8-40FF-B39D-4A70AD340374Q35082430-0CD23F8F-9655-4285-BC12-0C3FE84C229FQ35102253-EBEDD3D9-DEDE-4303-9F30-A03B9B4A610DQ35561048-F2B3C18A-4F8D-49CA-B8DB-50661B922A15Q35718644-3FEF90EC-D371-43B1-85C5-DF79A98FA828Q35833775-D4357023-824E-482D-B97D-0D8661156B8BQ35848366-1FC3478F-B6A3-4A1F-ADF4-A7CB2CF8B0F3Q36048199-97E03449-0C51-48FF-9921-FC487F84FDA4Q36249736-9601DA95-9A85-425A-9CCF-71A0336B7A8AQ36310443-ED438F27-EC26-4403-90A7-8B15AF5096D2Q36475259-306562C8-3E97-49B8-AA26-8BF728A3B1CEQ37087857-C5EAB190-3F3A-4DEF-B2BA-67717059F20EQ37150506-B1B7A4BC-964D-4274-86D6-90B2A2DCEC83Q37330454-B821723B-998B-41D9-8EB8-1B89D8C629A7Q37361369-1C4C3213-9B10-41DB-9305-447E7E80221CQ37383714-A8542F8B-7CF4-4552-9B7E-564993C5AD2AQ37394520-9F4D10DE-B238-48E5-86AF-2F4636037A2BQ37789411-CFB152ED-1261-44BC-92BB-EA7969A516E3Q37799656-3B30B39D-4DFE-4B82-90E8-2EDB263800C6Q37893829-55DCA400-CD34-49F6-B4E9-51C3E540FB98Q37898049-5200BD07-12D5-4EB2-BD2C-7E0105A6EF42Q37904710-51CF6EAC-09A4-4281-8914-A749F8470E77Q38031692-E80AFF79-B19B-4B7A-AF48-9E3726877B32Q38052121-E292819C-689B-43FB-8685-BA6184E35A7FQ38091181-7C0EAA95-3554-417E-9036-32AA29A66394Q38134107-910F9E09-CE76-4D57-AACE-11E2F653226DQ38816516-E1842C35-4460-4063-BCD7-21266184A0E9Q39688891-41D1CD92-99A1-46C3-B76A-0D79B208ED1FQ40203831-F011C059-0AF2-4216-B342-753021A442C7
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Roberto Mallone
@ast
Roberto Mallone
@en
Roberto Mallone
@es
Roberto Mallone
@nl
Roberto Mallone
@sl
type
label
Roberto Mallone
@ast
Roberto Mallone
@en
Roberto Mallone
@es
Roberto Mallone
@nl
Roberto Mallone
@sl
prefLabel
Roberto Mallone
@ast
Roberto Mallone
@en
Roberto Mallone
@es
Roberto Mallone
@nl
Roberto Mallone
@sl
P214
P1053
H-4430-2013
P106
P21
P214
P2798
P31
P3829
P496
0000-0002-9846-8861
P734
P735
P7859
viaf-313308260